Effects of Escherichia coli and Bacteroides fragilis on peritoneal host defenses

D. L. Dunn, R. A. Barke, D. C. Ewald, R. L. Simmons

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Escherichia coli and Bacteroides fragilis are common copathogens in clinical intra-abdominal sepsis, yet it is unclear how they interact synergistically in vivo. We sought to determine whether E. coli and B. fragilis, in combination but not alone, could exert a detrimental effect on the peritoneal host defenses of translymphatic absorption and bacterial phagocytosis. Our data indicated that noninvasive E. coli (O18ab:K56/K7:- and O111:B4), Klebsiella pneumoniae, B. fragilis, and Bacteroides thetaiotaomicron were handled in a similar fashion by both host defenses of the peritoneal cavity. The use of 2 x 108 nonviable radiolabeled E. coli as a tracer and either 2 x 109 B. fragilis or 2 x 109 E. coli (either viable or nonviable) as a competing agent to inhibit host defenses demonstrated that although clearance and phagocytosis could be inhibited, the inhibition occurred to a similar degree with either E. coli or B. fragilis. Thus, B. fragilis did not compete to any greater extent than E. coli did for peritoneal clearance or opsonization and phagocytosis in vivo. These data indicate that bacterial synergy probably does not occur on the basis of reduced peritoneal clearance or by a reduction in the opsonization and phagocytosis of either organism by the copathogen. These results provide indirect support for the hypothesis that in bacterial synergy, one organism directly stimulates the growth of the other, perhaps by providing a growth factor.

Original languageEnglish (US)
Pages (from-to)287-291
Number of pages5
JournalInfection and Immunity
Volume48
Issue number2
StatePublished - Jan 1 1985

Fingerprint

Bacteroides fragilis
Escherichia coli
Phagocytosis
Peritoneal Cavity
Klebsiella pneumoniae
Sepsis
Intercellular Signaling Peptides and Proteins
Growth

Cite this

Dunn, D. L., Barke, R. A., Ewald, D. C., & Simmons, R. L. (1985). Effects of Escherichia coli and Bacteroides fragilis on peritoneal host defenses. Infection and Immunity, 48(2), 287-291.

Effects of Escherichia coli and Bacteroides fragilis on peritoneal host defenses. / Dunn, D. L.; Barke, R. A.; Ewald, D. C.; Simmons, R. L.

In: Infection and Immunity, Vol. 48, No. 2, 01.01.1985, p. 287-291.

Research output: Contribution to journalArticle

Dunn, DL, Barke, RA, Ewald, DC & Simmons, RL 1985, 'Effects of Escherichia coli and Bacteroides fragilis on peritoneal host defenses', Infection and Immunity, vol. 48, no. 2, pp. 287-291.
Dunn DL, Barke RA, Ewald DC, Simmons RL. Effects of Escherichia coli and Bacteroides fragilis on peritoneal host defenses. Infection and Immunity. 1985 Jan 1;48(2):287-291.
Dunn, D. L. ; Barke, R. A. ; Ewald, D. C. ; Simmons, R. L. / Effects of Escherichia coli and Bacteroides fragilis on peritoneal host defenses. In: Infection and Immunity. 1985 ; Vol. 48, No. 2. pp. 287-291.
@article{4e1dcf6571b34ebc96c4e1c7ba418f31,
title = "Effects of Escherichia coli and Bacteroides fragilis on peritoneal host defenses",
abstract = "Escherichia coli and Bacteroides fragilis are common copathogens in clinical intra-abdominal sepsis, yet it is unclear how they interact synergistically in vivo. We sought to determine whether E. coli and B. fragilis, in combination but not alone, could exert a detrimental effect on the peritoneal host defenses of translymphatic absorption and bacterial phagocytosis. Our data indicated that noninvasive E. coli (O18ab:K56/K7:- and O111:B4), Klebsiella pneumoniae, B. fragilis, and Bacteroides thetaiotaomicron were handled in a similar fashion by both host defenses of the peritoneal cavity. The use of 2 x 108 nonviable radiolabeled E. coli as a tracer and either 2 x 109 B. fragilis or 2 x 109 E. coli (either viable or nonviable) as a competing agent to inhibit host defenses demonstrated that although clearance and phagocytosis could be inhibited, the inhibition occurred to a similar degree with either E. coli or B. fragilis. Thus, B. fragilis did not compete to any greater extent than E. coli did for peritoneal clearance or opsonization and phagocytosis in vivo. These data indicate that bacterial synergy probably does not occur on the basis of reduced peritoneal clearance or by a reduction in the opsonization and phagocytosis of either organism by the copathogen. These results provide indirect support for the hypothesis that in bacterial synergy, one organism directly stimulates the growth of the other, perhaps by providing a growth factor.",
author = "Dunn, {D. L.} and Barke, {R. A.} and Ewald, {D. C.} and Simmons, {R. L.}",
year = "1985",
month = "1",
day = "1",
language = "English (US)",
volume = "48",
pages = "287--291",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "2",

}

TY - JOUR

T1 - Effects of Escherichia coli and Bacteroides fragilis on peritoneal host defenses

AU - Dunn, D. L.

AU - Barke, R. A.

AU - Ewald, D. C.

AU - Simmons, R. L.

PY - 1985/1/1

Y1 - 1985/1/1

N2 - Escherichia coli and Bacteroides fragilis are common copathogens in clinical intra-abdominal sepsis, yet it is unclear how they interact synergistically in vivo. We sought to determine whether E. coli and B. fragilis, in combination but not alone, could exert a detrimental effect on the peritoneal host defenses of translymphatic absorption and bacterial phagocytosis. Our data indicated that noninvasive E. coli (O18ab:K56/K7:- and O111:B4), Klebsiella pneumoniae, B. fragilis, and Bacteroides thetaiotaomicron were handled in a similar fashion by both host defenses of the peritoneal cavity. The use of 2 x 108 nonviable radiolabeled E. coli as a tracer and either 2 x 109 B. fragilis or 2 x 109 E. coli (either viable or nonviable) as a competing agent to inhibit host defenses demonstrated that although clearance and phagocytosis could be inhibited, the inhibition occurred to a similar degree with either E. coli or B. fragilis. Thus, B. fragilis did not compete to any greater extent than E. coli did for peritoneal clearance or opsonization and phagocytosis in vivo. These data indicate that bacterial synergy probably does not occur on the basis of reduced peritoneal clearance or by a reduction in the opsonization and phagocytosis of either organism by the copathogen. These results provide indirect support for the hypothesis that in bacterial synergy, one organism directly stimulates the growth of the other, perhaps by providing a growth factor.

AB - Escherichia coli and Bacteroides fragilis are common copathogens in clinical intra-abdominal sepsis, yet it is unclear how they interact synergistically in vivo. We sought to determine whether E. coli and B. fragilis, in combination but not alone, could exert a detrimental effect on the peritoneal host defenses of translymphatic absorption and bacterial phagocytosis. Our data indicated that noninvasive E. coli (O18ab:K56/K7:- and O111:B4), Klebsiella pneumoniae, B. fragilis, and Bacteroides thetaiotaomicron were handled in a similar fashion by both host defenses of the peritoneal cavity. The use of 2 x 108 nonviable radiolabeled E. coli as a tracer and either 2 x 109 B. fragilis or 2 x 109 E. coli (either viable or nonviable) as a competing agent to inhibit host defenses demonstrated that although clearance and phagocytosis could be inhibited, the inhibition occurred to a similar degree with either E. coli or B. fragilis. Thus, B. fragilis did not compete to any greater extent than E. coli did for peritoneal clearance or opsonization and phagocytosis in vivo. These data indicate that bacterial synergy probably does not occur on the basis of reduced peritoneal clearance or by a reduction in the opsonization and phagocytosis of either organism by the copathogen. These results provide indirect support for the hypothesis that in bacterial synergy, one organism directly stimulates the growth of the other, perhaps by providing a growth factor.

UR - http://www.scopus.com/inward/record.url?scp=0021909238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021909238&partnerID=8YFLogxK

M3 - Article

VL - 48

SP - 287

EP - 291

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 2

ER -